FOX Business Flash top headlines for June 14
Check out what’s clicking on FoxBusiness.com.
An advisory committee to the FDA recommended Moderna's COVID-19 vaccine for emergency use authorization in children between the ages of 6 and 17 on Tuesday in a unanimous vote.
The FDA, which usually follows the advice of the committee, is likely to give final approval to Moderna's vaccine in this age group soon.
Pfizer's COVID-19 vaccine was approved for teenagers a year ago and was approved for kids between the ages of 5 and 11 last fall, but vaccination rates in these groups still lag the adult population.